{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:58Z","timestamp":1792014418698,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journalofhospitalinfection.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jhin.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:53:30Z","timestamp":1714179210000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Machine-learning-based risk assessment tool to rule out empirical use of ESBL-targeted therapy in endemic areas"],"prefix":"10.1016","volume":"149","author":[{"given":"H.D.","family":"Ravkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Ravkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2024.04.005_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2024.04.005_bib2","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/ciaa1581","article-title":"National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States","volume":"72","author":"Nelson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.04.005_bib3","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2468-2667(22)00225-0","article-title":"The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis","volume":"7","author":"Mestrovic","year":"2022","journal-title":"Lancet Publ Health"},{"key":"10.1016\/j.jhin.2024.04.005_bib4","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jhin.2024.04.005_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.cmi.2022.05.016","article-title":"Antibiotic management of urinary tract infections in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship","volume":"29","author":"Abbott","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2024.04.005_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.04.005_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2024.04.005_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cmi.2019.09.009","article-title":"Machine learning for clinical decision support in infectious diseases: a narrative review of current applications","volume":"26","author":"Peiffer-Smadja","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2024.04.005_bib9","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1093\/cid\/ciaa1576","article-title":"Predicting antibiotic resistance in hospitalized patients by applying machine learning to electronic medical records","volume":"72","author":"Lewin-Epstein","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.04.005_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciw425","article-title":"A\u00a0clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum \u03b2-lactamase-producing organism","volume":"63","author":"Goodman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.04.005_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/ice.2019.17","article-title":"A\u00a0methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: a case study using extended-spectrum beta-lactamase (ESBL) bacteremia","volume":"40","author":"Goodman","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2024.04.005_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s41591-019-0503-6","article-title":"Personal clinical history predicts antibiotic resistance of urinary tract infections","volume":"25","author":"Yelin","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jhin.2024.04.005_bib13","series-title":"Advances in Neural Information Processing Systems","article-title":"A\u00a0unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"key":"10.1016\/j.jhin.2024.04.005_bib14","series-title":"Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline","author":"Hindler","year":"2014"},{"key":"10.1016\/j.jhin.2024.04.005_bib15","first-page":"114","article-title":"Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region","volume":"63","author":"Hsueh","year":"2011","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhin.2024.04.005_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/antibiotics10020179","article-title":"Impact of an antibiotic stewardship program on the incidence of resistant Escherichia coli: a quasi-experimental study","volume":"10","author":"Ziv-On","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jhin.2024.04.005_bib17","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1093\/cid\/ciaa1397","article-title":"Using prior culture results to improve initial empiric antibiotic prescribing: an evaluation of a simple clinical heuristic","volume":"72","author":"Elligsen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.04.005_bib18","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1093\/cid\/ciaa921","article-title":"Improving Decision Making in Empiric Antibiotic Selection (IDEAS) for Gram-negative bacteremia: a prospective clinical implementation study","volume":"73","author":"Elligsen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.04.005_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3201\/eid2904.221552","article-title":"Challenges in forecasting antimicrobial resistance","volume":"29","author":"Pei","year":"2023","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T04:29:53Z","timestamp":1719376193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670124001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":19,"alternative-id":["S0195670124001270"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2024.04.005","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine-learning-based risk assessment tool to rule out empirical use of ESBL-targeted therapy in endemic areas","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}